Sotac Pharmaceuticals Limited (NSE:SOTAC)

India flag India · Delayed Price · Currency is INR
122.50
-0.50 (-0.41%)
At close: Sep 17, 2025
-0.41%
Market Cap1.35B
Revenue (ttm)1.05B
Net Income (ttm)44.60M
Shares Out11.05M
EPS (ttm)4.04
PE Ratio30.36
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,400
Average Volume5,460
Open123.10
Previous Close123.00
Day's Range122.50 - 123.10
52-Week Range88.05 - 152.35
Beta0.18
RSI46.28
Earnings DateOct 29, 2025

About Sotac Pharmaceuticals

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India. Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron, anti-cold, anti-allergic, dermatological products, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics IP-lactams and non-IP-lactams, anti-fungal, and cephalosporin. The company also offers beta and ... [Read more]

Industry Pharmaceutical Preparations
Founded 2014
Employees 68
Stock Exchange National Stock Exchange of India
Ticker Symbol SOTAC
Full Company Profile

Financial Performance

In 2023, Sotac Pharmaceuticals's revenue was 1.04 billion, an increase of 34.13% compared to the previous year's 774.83 million. Earnings were 42.81 million, an increase of 48.69%.

Financial Statements

News

There is no news available yet.